Intarcia Gets Its Hearing: FDA Panel To Weigh Nonapproval Of Diabetes Drug/Device Combo In September

 
• By Sue Sutter
  
Boxing gloves
FDA and Intarcia will duke it out at an Endocrinologic and Metabolic Drugs Advisory Committee meeting on 21 September. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers